Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: A systematic review and meta-analysis
Clinical Infectious Diseases | Feb 08, 2018
Natori Y, et al. - A systematic review and meta-analysis is performed to support the validity of viral load as an appropriate surrogate end-point in clinical studies of cytomegalovirus in solid organ transplantation. Findings suggested that cytomegalovirus (CMV) load is an appropriate surrogate endpoint for CMV trials in organ transplant recipients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries